MedTrace Logo

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)

NCT05819307 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-04-19

No results posted yet for this study

Summary

To investigate the feasibility of a combined OCT/FLIM device

Conditions

  • Retinal Disease

Interventions

DEVICE

OCT/FLIM

OCT/FLIM imaging of the retina

Sponsors & Collaborators

  • Haag-Streit AG

    collaborator INDUSTRY

  • University of Bern

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Martin S. Zinkenagel, Prof.Dr.Dr. · Clinic director

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-12-31
Completion
2024-05-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819307 on ClinicalTrials.gov